Literature DB >> 12355450

Chemotactic agents induce IL-6Ralpha shedding from polymorphonuclear cells: involvement of a metalloproteinase of the TNF-alpha-converting enzyme (TACE) type.

Valérie Marin1, Félix Montero-Julian, Sandra Grès, Pierre Bongrand, Catherine Farnarier, Gilles Kaplanski.   

Abstract

Interleukin (IL)-6 transsignaling plays a pivotal role in the shift from neutrophil to monocyte recruitment at the inflammatory site. Release of neutrophil IL-6 receptor-alpha (IL-6Ralpha, CD126) in its soluble form is a key step of IL-6 transsignaling, however, its physiological inducers are poorly known. Here, we observed that the neutrophil chemoattractants IL-8, C5a complement fraction, platelet activating factor, leukotriene B4 and N-formyl-methionyl-leucyl-phenylalanine rapidly decreased IL-6Ralpha membrane expression and increased soluble IL-6Ralpha concentrations in the neutrophil supernatants, consistent with a shedding process. IL-6Ralpha shedding involved a TNF-alpha-converting enzyme-type metalloproteinase since it was partly decreased in the presence of a specific inhibitor, but not cathepsin G since PMSF or alpha1 antichymotrypsin had no effect. Neutrophil IL-6Ralpha shedding may be a common feature of neutrophilic infiltrates in various inflammatory situations, allowing IL-6 transsignaling, decreasing neutrophil infiltration and in the meantime favoring monocyte recruitment, thus the initiation of an immune response and subsequently the resolution of inflammation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12355450     DOI: 10.1002/1521-4141(2002010)32:10<2965::AID-IMMU2965>3.0.CO;2-V

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  17 in total

Review 1.  Interleukin-6 in aging and chronic disease: a magnificent pathway.

Authors:  Marcello Maggio; Jack M Guralnik; Dan L Longo; Luigi Ferrucci
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2006-06       Impact factor: 6.053

2.  Interaction of human peripheral blood monocytes with apoptotic polymorphonuclear cells.

Authors:  Tomasz P Mikołajczyk; Joanna E Skrzeczyńska-Moncznik; Mirosław A Zarebski; Ewa A Marewicz; Anna M Wiśniewska; Magdalena Dzieba; Jerzy W Dobrucki; Juliusz R Pryjma
Journal:  Immunology       Date:  2009-09       Impact factor: 7.397

Review 3.  Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling.

Authors:  Simon A Jones; Jürgen Scheller; Stefan Rose-John
Journal:  J Clin Invest       Date:  2011-09-01       Impact factor: 14.808

Review 4.  ADAM-17: the enzyme that does it all.

Authors:  Monika Gooz
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-04       Impact factor: 8.250

Review 5.  IL-6 as a keystone cytokine in health and disease.

Authors:  Christopher A Hunter; Simon A Jones
Journal:  Nat Immunol       Date:  2015-05       Impact factor: 25.606

6.  Upregulation of tumor necrosis factor receptor 1 and TNF-alpha converting enzyme during corneal wound healing.

Authors:  Tohru Sakimoto; Ai Yamada; Hitoshi Kanno; Mitsuru Sawa
Journal:  Jpn J Ophthalmol       Date:  2008-11-11       Impact factor: 2.447

7.  Regulation of the receptor for TNFalpha, TNFR1, in human conjunctival epithelial cells.

Authors:  Ellen B Cook; James L Stahl; Frank M Graziano; Neal P Barney
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-05-16       Impact factor: 4.799

8.  ADAM17 mRNA expression and pathological features of hepatocellular carcinoma.

Authors:  Xiang Ding; Lian-Yue Yang; Gen-Wen Huang; Wei Wang; Wei-Qun Lu
Journal:  World J Gastroenterol       Date:  2004-09-15       Impact factor: 5.742

9.  Cross-domain inhibition of TACE ectodomain.

Authors:  Christopher J Tape; Sofie H Willems; Sarah L Dombernowsky; Peter L Stanley; Marton Fogarasi; Willem Ouwehand; John McCafferty; Gillian Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-17       Impact factor: 11.205

10.  Endothelial activation and apoptosis mediated by neutrophil-dependent interleukin 6 trans-signalling: a novel target for systemic sclerosis?

Authors:  Theresa C Barnes; David G Spiller; Marina E Anderson; Steven W Edwards; Robert J Moots
Journal:  Ann Rheum Dis       Date:  2010-11-10       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.